RTW INVESTMENTS, LP
NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$9.92B2026 Q3
Positions83
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.43.4%
What Changed This Quarter?
Top Holdings
PTGX
Protagonist Therapeutics
7.2%
ARGX
Argenx
6.9%
CGON
CG Oncology
6.1%
IRTC
iRhythm
3.6%
INSM
Insmed
3.6%
TNGX
Tango Therapeutics
3.5%
ERAS
Erasca
3.3%
SYRE
Spyre Therapeutics
3.3%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.